JAK3 and acute lymphoblastic leukemia: JAK1/3 mutations have been associated with early T-cell precursor ALL (ETP-ALL), and JAK3 mutations have been detected in acute megakaryoblastic leukemia [83], extranodal nasal-type natural killer cell lymphoma, and T-cell prolymphocytic leukemia [84].